These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 21543800)

  • 1. Proteostasis: a new therapeutic paradigm for pulmonary disease.
    Bouchecareilh M; Balch WE
    Proc Am Thorac Soc; 2011 May; 8(2):189-95. PubMed ID: 21543800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha 1-Antitrypsin Deficiency: A Disorder of Proteostasis-Mediated Protein Folding and Trafficking Pathways.
    Karatas E; Bouchecareilh M
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA)-mediated correction of α1-antitrypsin deficiency.
    Bouchecareilh M; Hutt DM; Szajner P; Flotte TR; Balch WE
    J Biol Chem; 2012 Nov; 287(45):38265-78. PubMed ID: 22995909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteostasis strategies for restoring alpha1-antitrypsin deficiency.
    Bouchecareilh M; Conkright JJ; Balch WE
    Proc Am Thorac Soc; 2010 Nov; 7(6):415-22. PubMed ID: 21030523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteostasis, an emerging therapeutic paradigm for managing inflammatory airway stress disease.
    Bouchecareilh M; Balch WE
    Curr Mol Med; 2012 Aug; 12(7):815-26. PubMed ID: 22697348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alpha-1 antitrypsin deficiency: A model of alteration of protein homeostasis or proteostasis].
    Vignaud H; Cullin C; Bouchecareilh M
    Rev Mal Respir; 2015 Dec; 32(10):1059-71. PubMed ID: 26386628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha1-antitrypsin deficiency: biological answers to clinical questions.
    Coakley RJ; Taggart C; O'Neill S; McElvaney NG
    Am J Med Sci; 2001 Jan; 321(1):33-41. PubMed ID: 11202478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteostasis impairment in protein-misfolding and -aggregation diseases.
    Hipp MS; Park SH; Hartl FU
    Trends Cell Biol; 2014 Sep; 24(9):506-14. PubMed ID: 24946960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alpha-1-antitrypsin deficiency].
    Bouchecareilh M
    Med Sci (Paris); 2014 Oct; 30(10):889-95. PubMed ID: 25311024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proteostasis boundary in misfolding diseases of membrane traffic.
    Hutt DM; Powers ET; Balch WE
    FEBS Lett; 2009 Aug; 583(16):2639-46. PubMed ID: 19708088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of oral 4-phenylbutyrate on serum alpha-1-antitrypsin in patients with alpha-1-antitrypsin deficiency: a preliminary study.
    Teckman JH
    J Pediatr Gastroenterol Nutr; 2004 Jul; 39(1):34-7. PubMed ID: 15187777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling general proteostasis: proteome balance in health and disease.
    Roth DM; Balch WE
    Curr Opin Cell Biol; 2011 Apr; 23(2):126-34. PubMed ID: 21131189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical Biology Framework to Illuminate Proteostasis.
    Sebastian RM; Shoulders MD
    Annu Rev Biochem; 2020 Jun; 89():529-555. PubMed ID: 32097570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergent properties of proteostasis in managing cystic fibrosis.
    Balch WE; Roth DM; Hutt DM
    Cold Spring Harb Perspect Biol; 2011 Feb; 3(2):. PubMed ID: 21421917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapleural administration of an AAVrh.10 vector coding for human α1-antitrypsin for the treatment of α1-antitrypsin deficiency.
    Chiuchiolo MJ; Kaminsky SM; Sondhi D; Hackett NR; Rosenberg JB; Frenk EZ; Hwang Y; Van de Graaf BG; Hutt JA; Wang G; Benson J; Crystal RG
    Hum Gene Ther Clin Dev; 2013 Dec; 24(4):161-73. PubMed ID: 24191907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological and chemical approaches to diseases of proteostasis deficiency.
    Powers ET; Morimoto RI; Dillin A; Kelly JW; Balch WE
    Annu Rev Biochem; 2009; 78():959-91. PubMed ID: 19298183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoplasmic reticulum polymers impair luminal protein mobility and sensitize to cellular stress in alpha1-antitrypsin deficiency.
    Ordóñez A; Snapp EL; Tan L; Miranda E; Marciniak SJ; Lomas DA
    Hepatology; 2013 May; 57(5):2049-60. PubMed ID: 23197448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracing genetic diversity captures the molecular basis of misfolding disease.
    Zhao P; Wang C; Sun S; Wang X; Balch WE
    Nat Commun; 2024 Apr; 15(1):3333. PubMed ID: 38637533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alpha-1 antitrypsin deficiency 50 years later].
    Mornex JF
    Bull Acad Natl Med; 2014; 198(4-5):757-66. PubMed ID: 26753407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.